RENZOPA Trademark

Trademark Overview

On Monday, August 26, 2013, a trademark application was filed for RENZOPA with the United States Patent and Trademark Office. The USPTO has given the RENZOPA trademark a serial number of 86048323. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 27, 2017. This trademark is owned by Bristol-Myers Squibb Company. The RENZOPA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
renzopa

General Information

Serial Number86048323
Word MarkRENZOPA
Filing DateMonday, August 26, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 27, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 26, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 5, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, November 27, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 27, 2017ABANDONMENT - NO USE STATEMENT FILED
Friday, April 28, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 27, 2017EXTENSION 5 GRANTED
Friday, April 21, 2017EXTENSION 5 FILED
Friday, April 21, 2017TEAS EXTENSION RECEIVED
Tuesday, October 25, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 24, 2016EXTENSION 4 GRANTED
Friday, October 21, 2016EXTENSION 4 FILED
Friday, October 21, 2016TEAS EXTENSION RECEIVED
Saturday, May 28, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 27, 2016EXTENSION 3 GRANTED
Thursday, April 21, 2016EXTENSION 3 FILED
Friday, May 27, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 21, 2016TEAS EXTENSION RECEIVED
Tuesday, November 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 2, 2015EXTENSION 2 GRANTED
Wednesday, October 21, 2015EXTENSION 2 FILED
Monday, November 2, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 21, 2015TEAS EXTENSION RECEIVED
Wednesday, March 25, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 23, 2015EXTENSION 1 GRANTED
Monday, March 23, 2015EXTENSION 1 FILED
Monday, March 23, 2015TEAS EXTENSION RECEIVED
Tuesday, October 21, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 26, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 26, 2014PUBLISHED FOR OPPOSITION
Wednesday, August 6, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, July 19, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 8, 2014ASSIGNED TO LIE
Wednesday, June 18, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 17, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 16, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 16, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 16, 2013NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, December 16, 2013PRIORITY ACTION E-MAILED
Monday, December 16, 2013PRIORITY ACTION WRITTEN
Tuesday, December 10, 2013ASSIGNED TO EXAMINER
Thursday, September 5, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 29, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

renzopa diseases pharmaceutical human anti preparations disorders organ solid auto immune